Table 5 Distribution of antimicrobial susceptibility test results of 131 methicillin-sensitive Staphylococcus aureus isolates from pediatric patients stratified by origin of acquisition
Antibiotics | CA (n = 94) No. (%) | HA (n = 37) No. (%) | P | HA | ||
|---|---|---|---|---|---|---|
CO (n = 17) No. (%) | HO (n = 20) No. (%) | P | ||||
Clindamycin (%) | 75 (80) | 29 (78) | 0.858 | 12 (71) | 17 (85) | 0.289 |
Erythromycin (%) | 66 (70) | 25 (68) | 0.767 | 11 (65) | 14 (70) | 0.732 |
Fusidic acid (%) | 93 (99) | 35 (95) | 0.135 | 17 (100) | 18 (90) | 0.180 |
Linezolid (%) | 94 (100) | 36/36a (100) | – | 17 (100) | 19/19a (100) | – |
Penicillin (%) | 2 (2) | 8/36a (22) | 0 | 4 (24) | 4/19a (21) | 0.858 |
Sufamethoxazole-Trimethoprim (%) | 94 (100) | 34/36a (94) | 0.021 | 16 (94) | 18/19a (95) | 0.935 |
Teicoplanin (%) | 94 (100) | 36/36a (100) | – | 17 (100) | 19/19a (100) | – |
Vancomycin (%) | 94 (100) | 36/36a (100) | – | 17 (100) | 19/19a (100) | – |
iprofloxacin (%) | 93 (99) | 37 (100) | 0.529 | 17 (100) | 20 (100) | – |
Doxycycline (%) | 92 (98) | 35 (95) | 0.326 | 15 (88) | 20 (100) | 0.115 |